Acme Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:3em;'>ACM</div>
ACU -- USA Stock  

USD 32.33  0.07  0.22%

Acme Payout Ratio is comparatively stable at the moment as compared to the past year. Acme reported Payout Ratio of 0.29 in 2019. Price to Book Value is likely to gain to 1.53 in 2020, whereas Average Equity is likely to drop slightly above 50.8 M in 2020. If you have been following Acme you may be considering acquiring. Let's check if stable basic indicators will continue to push the price to gain for Acme's private investors. We currently estimate Acme as overvalued. The real value is approaching 22.31 per share.
Published over a month ago
View all stories for Acme | View All Stories
How stable are Acme (NYSEMKT:ACU) basic indicators given the newest gain?
Our investment recommendation module complements current analysts and expert consensus on Acme. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. The company dividends can provide a clue to the current value of the stock. This firm one year expected dividend income is about $0.28 per share.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Acme income statement, its balance sheet, and the statement of cash flows. Potential Acme investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Acme investors may use each financial statement separately, they are all related. The changes in Acme's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acme's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of Acme fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Acme performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Acme shares is the value that is considered the true value of the share. If the intrinsic value Acme is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Acme. Please read more on our fundamental analysis page.

And What about dividends?

A dividend is the distribution of a portion of Acme earnings, decided and managed by the company's board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Acme dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment. Acme one year expected dividend income is about $0.28 per share.
Payment of Dividends and Other Cash Distributions is likely to drop to about (1.7 M) in 2020. Dividend Yield is likely to drop to 0.0199 in 2020.
Last ReportedProjected for 2020
Payment of Dividends and Other Cash Distributions-1.6 M-1.7 M
Dividend Yield 0.02  0.0199 
Dividends per Basic Common Share 0.48  0.45 
Investing in dividend-paying stocks, such as Acme is one of the few strategies that are good for long-term investment. Ex-dividend dates are significant because investors in Acme must own a stock before its ex-dividend date to receive its next dividend. This type of analysis is very useful when you want to generate a past dividend schedule and payout information for Acme. Then that information in the form of graph and calendar can be used to fully explain how Du Pont dividends can provide a real clue to its valuation.

How important is Acme's Liquidity

Acme financial leverage refers to using borrowed capital as a funding source to finance Acme ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Acme financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Acme's total debt and its cash.

How Acme utilizes its cash?

To perform a cash flow analysis of Acme, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Acme is receiving and how much cash it distributes out in a given period. The Acme cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Acme Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Acme reported Net Cash Flow from Operations of 14.7 Million in 2019

Acme Gross Profit

Acme Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Acme previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Acme Gross Profit growth over the last 10 years. Please check Gross Profit in more details.

Breaking down Acme Indicators

Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Acme is not uncomon. Many companies such as Acme have both institutions investors and insiders sharing the ownership. Retail investors typically buy and sell stocks in round lots of 100 shares or more. Other other hand institutional investors are known to buy and sell in block trades of 10,000 shares or more. Let's take a look at how the ownership of Acme is distributed among investors.

Ownership Allocation

The market capitalization of Acme is currently $86.41 Million. Over half of Acme outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Acme. Please watch out for any change in the institutional holdings of Acme as this could mean something significant has changed or about to change at the company. Please note that no matter how profitable the entity is or how much assets it hold, if the real value is less than what market suggests, you will most likely generate negative returns and should consider selling it at some point.

Retail Investors
22.41%
Insiders
12.4%
Institutions
65.19%
Retail Investors22.41
Insiders12.4
Institutions65.19
 2017 2018 2019 2020 (projected)
Cost of Revenue82.65 M86.67 M90.46 M85.2 M
Consolidated Income4.05 M4.6 M5.51 M5.29 M

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Acme has an asset utilization ratio of 185.06 percent. This implies that the company is making $1.85 for each dollar of assets. An increasing asset utilization means that Acme is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
72.5 M
Assets Non Current
31.6 M
Current Assets72.52 Million59.63
Assets Non Current31.6 Million25.99
Goodwill17.38 Million14.29
Tax Assets104,7030.0861

Acme is expecting lower volatility in November

Newest Sortino Ratio is up to 0.05. Price may drop again. Acme currently demonstrates below-verage downside deviation. It has Information Ratio of 0.04 and Jensen Alpha of 0.17. However, we do advice investors to further question Acme expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

Our Final Take On Acme

Whereas other companies within the household & personal products industry are still a little expensive, even after the recent corrections, Acme may offer a potential longer-term growth to private investors. To conclude, as of the 21st of October 2020, our overall 30 days buy-hold-sell advice on the firm is Hold. We believe Acme is overvalued with below average probability of bankruptcy for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Acme. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com